Literature DB >> 19152562

A review of guidelines for sedation, anesthesia,and alternative interventions for people with special needs.

Paul Glassman1.   

Abstract

There are significant numbers of people in our society with disabilities or other special needs. Their number and percentage are growing, in some cases, dramatically. Many of these individuals need special support in order to receive dental treatment. Modalities that can be used to provide dental treatment include pharmacological approaches to produce various levels of sedation or anesthesia. In addition to the use of medications, there are also techniques that employ behavioral or psychological interventions. In some circumstances, physical support or protective stabilization is used. There are also social supports and prevention strategies that can impact the individual's preparation for and need for dental treatment. This review of the numerous guidelines, which have been published for the use of sedation and anesthesia to facilitate the delivery of dental treatment, indicates that there are fewer guidelines for the inclusion of behavioral or psychological interventions or for the incorporation of social supports or prevention strategies. In addition, most published guidelines do not include considerations for people with special needs. There is a need for increased research and documentation of combined treatment modalities, and these combined approaches need to be incorporated into guidelines for patient care for people with special needs. There is also a need to advocate for reimbursement systems that support all appropriate treatment options so that practitioners can be free to recommend treatment options based on the efficacy and safety of each option.

Entities:  

Mesh:

Year:  2009        PMID: 19152562     DOI: 10.1111/j.1754-4505.2008.00056.x

Source DB:  PubMed          Journal:  Spec Care Dentist        ISSN: 0275-1879


  8 in total

1.  Risk factors with intravenous sedation for patients with disabilities.

Authors:  Fumihiro Yoshikawa; Yoh Tamaki; Hisa Okumura; Zenzo Miwa; Masaaki Ishikawa; Kazuhiro Shimoyama; Zenkou Nakamura; Hitomi Kunimori; Shigeharu Jinno; Hikaru Kohase; Haruhisa Fukayama
Journal:  Anesth Prog       Date:  2013

2.  A cost analysis estimation of a single episode of comprehensive dental treatment under general anaesthesia for adults with disabilities.

Authors:  D McGeown; S Stapleton; J Nunn
Journal:  Br Dent J       Date:  2018-03-16       Impact factor: 1.626

Review 3.  The use of general anesthesia to facilitate dental treatment in adult patients with special needs.

Authors:  Mathew Albert Wei Ting Lim; Gelsomina Lucia Borromeo
Journal:  J Dent Anesth Pain Med       Date:  2017-06-29

Review 4.  Two decades of ART: improving on success through further research.

Authors:  Christopher J Holmgren; Márcia Cançado Figueredo
Journal:  J Appl Oral Sci       Date:  2009       Impact factor: 2.698

5.  Conscious sedation procedures using intravenous midazolam for dental care in patients with different cognitive profiles: a prospective study of effectiveness and safety.

Authors:  Valérie Collado; Denise Faulks; Emmanuel Nicolas; Martine Hennequin
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

6.  Premedication with midazolam in intellectually disabled dental patients: intramuscular or oral administration? A retrospective study.

Authors:  H Hanamoto; A Boku; M Sugimura; A Oyamaguchi; M Inoue; H Niwa
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-07-01

7.  Outpatient dental care for people with disabilities under general anaesthesia in Switzerland.

Authors:  Julia Jockusch; Bernhard A J Sobotta; Ina Nitschke
Journal:  BMC Oral Health       Date:  2020-08-18       Impact factor: 2.757

8.  Outpatient, dental care of adult vulnerable patients under general anaesthesia-a retrospective evaluation of need for treatment and dental follow-up care.

Authors:  Julia Jockusch; Werner Hopfenmüller; Ronald Ettinger; Ina Nitschke
Journal:  Clin Oral Investig       Date:  2020-09-15       Impact factor: 3.573

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.